BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16523015)

  • 21. Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution.
    Roulin D; Matter M; Bady P; Liénard D; Gugerli O; Boubaker A; Bron L; Lejeune FJ
    Eur J Surg Oncol; 2008 Jun; 34(6):673-9. PubMed ID: 17825518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma.
    Barnhill RL; Katzen J; Spatz A; Fine J; Berwick M
    J Cutan Pathol; 2005 Apr; 32(4):268-73. PubMed ID: 15769275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
    Lasithiotakis K; Leiter U; Meier F; Eigentler T; Metzler G; Moehrle M; Breuninger H; Garbe C
    Cancer; 2008 Apr; 112(8):1795-804. PubMed ID: 18306371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma.
    Schlagenhauff B; Ellwanger U; Breuninger H; Stroebel W; Rassner G; Garbe C
    Melanoma Res; 2000 Apr; 10(2):165-9. PubMed ID: 10803717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI).
    Testori A; De Salvo GL; Montesco MC; Trifirò G; Mocellin S; Landi G; Macripò G; Carcoforo P; Ricotti G; Giudice G; Picciotto F; Donner D; Di Filippo F; Soteldo J; Casara D; Schiavon M; Vecchiato A; Pasquali S; Baldini F; Mazzarol G; Rossi CR;
    Ann Surg Oncol; 2009 Jul; 16(7):2018-27. PubMed ID: 19132446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit.
    McKinnon JG; Yu XQ; McCarthy WH; Thompson JF
    Cancer; 2003 Sep; 98(6):1223-31. PubMed ID: 12973846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BANS: a discussion of the problem.
    Bernengo MG; Reali UM; Doveil GC; Cappello N; Lisa F; Moretti S
    Melanoma Res; 1992 Sep; 2(3):157-62. PubMed ID: 1450669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
    Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
    J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of periodic acid-Schiff-positive patterns in primary cutaneous melanoma.
    Warso MA; Maniotis AJ; Chen X; Majumdar D; Patel MK; Shilkaitis A; Gupta TK; Folberg R
    Clin Cancer Res; 2001 Mar; 7(3):473-7. PubMed ID: 11297236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex differences in survival of cutaneous melanoma are age dependent: an analysis of 7338 patients.
    Mervic L; Leiter U; Meier F; Eigentler T; Forschner A; Metzler G; Bartenjev I; Büttner P; Garbe C
    Melanoma Res; 2011 Jun; 21(3):244-52. PubMed ID: 21540649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness.
    Crocetti E; Carli P
    Eur J Dermatol; 2003; 13(1):72-5. PubMed ID: 12609787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis.
    Chagpar RB; Ross MI; Reintgen DS; Edwards MJ; Scoggins CR; Martin RC; Noyes RD; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Davidson BS; Sussman JJ; McMasters KM
    J Surg Res; 2007 Nov; 143(1):164-8. PubMed ID: 17950088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of surveillance programme aimed at early diagnosis of cutaneous melanoma in high risk Mediterranean subjects.
    Carli P; Balzi D; de Giorgi V; Massi D; Palli D; Chiarugi A; Nardini P; Giannotti B
    Eur J Dermatol; 2003; 13(5):482-6. PubMed ID: 14693495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel role for RGS1 in melanoma progression.
    Rangel J; Nosrati M; Leong SP; Haqq C; Miller JR; Sagebiel RW; Kashani-Sabet M
    Am J Surg Pathol; 2008 Aug; 32(8):1207-12. PubMed ID: 18580492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
    Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
    Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center.
    Sassen S; Shaw HM; Colman MH; Scolyer RA; Thompson JF
    Ann Surg Oncol; 2008 Feb; 15(2):630-7. PubMed ID: 18080717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base.
    Lange JR; Palis BE; Chang DC; Soong SJ; Balch CM
    J Clin Oncol; 2007 Apr; 25(11):1363-8. PubMed ID: 17416855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival analysis of malignant melanoma in Japan--multivariate analysis of prognostic factors.
    Uehara S; Kamo R; Harada T; Ishii M
    Osaka City Med J; 2009 Jun; 55(1):35-52. PubMed ID: 19725433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-infiltrating lymphocytes predict cutaneous melanoma survival.
    Fortes C; Mastroeni S; Mannooranparampil TJ; Passarelli F; Zappalà A; Annessi G; Marino C; Caggiati A; Russo N; Michelozzi P
    Melanoma Res; 2015 Aug; 25(4):306-11. PubMed ID: 25933208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients.
    Kölmel KF; Grange JM; Krone B; Mastrangelo G; Rossi CR; Henz BM; Seebacher C; Botev IN; Niin M; Lambert D; Shafir R; Kokoschka EM; Kleeberg UR; Gefeller O; Pfahlberg A
    Eur J Cancer; 2005 Jan; 41(1):118-25. PubMed ID: 15617996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.